RevCycleAI Brief
Published researchAI chart-review company selling one engine to providers and health plans. Charta for Providers reviews every chart before claim submission against coding guidelines, payer rules, and the organization's clinical protocols, with findings surfaced for human approval inside the EHR. Charta for Payers, launched with the Nov. 10, 2026 Series B, covers retrospective HCC coding, second-pass coding, a smart coding platform, prospective risk-adjustment intelligence, HCC validation and audit workflow, and HEDIS and quality care-gap detection.
✦ Ask RevCycleAI about Charta Health
Pro AI analystGo deeper on competitors, positioning, buyers, funding and market signals.
Unlock Ask RevCycleAI →Key findings
Research highlightsThe company release says provider findings surface for human approval inside the EHR. Insight's Nov. 10, 2026 investment note says simple issues are corrected automatically and nuanced issues route to the clinician. Confirm which control is in the contract.
The 10x revenue figure is company-reported and has no base revenue. No valuation was disclosed.
Payer-side HCC coding and provider-side coding integrity do not share a P&L. Ask which of the six payer products is in scope, and which unnamed insurer helped design them.
Charta Health raises $55 million Series B led by Insight Partners
RevCycleAI Intelligence Scores
MethodologyMarket Matrix: Major Contender · Impact 55 · Capability 46
Funding & transaction history
1 trackedCharta Health announced a $55 million Series B on Nov. 10, 2026, led by Insight Partners. Existing investors Madrona, Bain Capital Ventures, and South Park Commons participated, alongside QuantumLight. The company says total funding is $85 million and that this is its third round in under two years. It says revenue grew 10x in the last 12 months with health plans and provider organizations. No valuation was disclosed. The round launches Charta for Providers and Charta for Payers on one AI engine. Charta for Payers, designed with an unnamed large health insurer, lists six products: retrospective HCC coding, AI-automated second-pass coding, a smart coding platform, prospective risk adjustment intelligence, HCC validation and audit workflow, and HEDIS and quality care gap detection. Named provider customers are American Family Care, Grow Therapy, and Pediatric Associates Family of Companies. The July 22, 2025 Series A was $22 million led by Bain Capital Ventures and is a separate round.